高级检索
当前位置: 首页 > 详情页

Serum lactate concentration on admission to hospital predicts the postoperative mortality of elderly patients with hip fractures 30 days after surgery

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 预警期刊

机构: [1]Department of Orthopaedics, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China [2]Department of Orthopaedics, The Seventh Medical Center, Chinese PLA General Hospital, Beijing 100700, China
出处:
ISSN:

关键词: Hip fracture elderly lactate concentration 30-day mortality predictor

摘要:
Purpose: To determine whether serum lactate concentration on admission to hospital is a predictor for 30-day and 1-year mortality for patients who underwent hip-surgery. Methods: Data from elderly patients with hip fractures admitted to our hospital (Jan 2012-Dec 2016) were reviewed. The lactate concentration on admission was assessed using a cut-off value of 2.0 mmol/L and then a new cut-off value was determined by maximizing the Youden index. Multivariate logistic regression was employed to verify whether a higher lactate concentration compared with the cutoff value was an independent risk factor for postoperative mortality after 30 days or at 1 year. Results: A total of 1,004 patients were enrolled. There were differences in the incidence of postoperative complications (28.6% vs. 21.9%, P = 0.022), length of stay (13.56 +/- 8.66 vs. 12.47 +/- 7.81 days, P = 0.047), 30-day mortality (10.8% vs. 1.3%, P < 0.001), 1-year mortality (23.3% vs. 11.8%, P < 0.001) and survival time (23.92 +/- 16.58 vs. 28.81 +/- 16.54 months, P < 0.001) between the 0.001) with a cutoff value of lactate >= 2.35 mmol/L (sensitivity = 0.744, specificity = 0.834). Multivariate analysis revealed that a serum lactate concentration 0.001) mortality. Conclusion: The admission lactate concentration (>= 2.35 mmol/L) following hip fracture derived by this study was a significant predictor of mortality 30 days after surgery, which might help physicians to stratify the risk for these patients.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验 3 区 肿瘤学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL Q2 ONCOLOGY
最新[2023]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of Orthopaedics, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China [2]Department of Orthopaedics, The Seventh Medical Center, Chinese PLA General Hospital, Beijing 100700, China
通讯作者:
通讯机构: [2]Department of Orthopaedics, The Seventh Medical Center, Chinese PLA General Hospital, Beijing 100700, China [*1]Department of Orthopaedics, The Seventh Medi-cal Center, Chinese PLA General Hospital, No. 5 Nanmencang, Beijing 100700, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)